Health Condition 1: L811- Chloasma
Conditions
Interventions
Intervention1: Individualized Homoeopathic Medicine: Pill form of administration
Oral route of administration
30 Pill size
Centesimal scale
First dose after initial case taking
Repetition of dose acco
Sponsors
Bakson Homoeopathic Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Adults aged between 18 to 59 years irrespective of Gender Individuals diagnosed clinically with mild to severe facial Melasma assessed using Modified Melasma Area and Severity Index mMASI Participants with duration of Melasma for more than 3 months Participants willing to give written informed consent for participation and photographic documentation
Exclusion criteria
Exclusion criteria: Cases of Melasma on extra Facial sites Participants undergoing active Conventional treatment for Melasma Participants using any Topical applications including skin lightening products Participants with pigmentation due to other dermatological conditions Participants on Oral Contraceptive Pills or Hormonal therapy or with a history of use in the past 6 months Participants with unprotected sun exposure more than 2 hours per day Participants suffering from severe systemic disorders including uncontrolled hypothyroidism immunocompromised conditions autoimmune diseases Diagnosed cases of Psychiatric illness and cognitive impairment Pregnant and Lactating females Participants who have received any treatment for melasma within last 4 weeks thereby not fulfilling the required washout period prior to study enrolment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessing the effect on Melasma using Modified Melasma Area and Severity Index mMASI after giving Individualized Homoeopathic MedicineTimepoint: 16 months study 6 month enrollment 6 month follow up 2 month data analysis 2 month report writing Modified Melasma Area and Severity Index to be used at Baseline 3 month 6 month Statistical analysis to be done at Baseline 3 month 6 month | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessing the effect on quality of life of participants using the Melasma Quality of Life Scale MelasQoL after giving Individualized Homoeopathic MedicineTimepoint: 16 months study 6 month enrollment 6 month follow up 2 month data analysis 2 month report writing Melasma Quality of Life Index to be used at Baseline 3 month 6 month Statistical analysis to be done at Baseline 3 month 6 month | — |
Countries
India
Contacts
Public ContactDr Akshay Mathur
Bakson Homoeopathic Medical College and Hospital
Outcome results
None listed